Skip to content

Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with myelodysplastic syndrome (prospective observational study)

Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with myelodysplastic syndrome (prospective observational study) - Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with myelodysplastic syndrome (prospective observational study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035068
Enrollment
100
Registered
2018-12-15
Start date
2018-12-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myelodysplastic syndrome

Interventions

None listed

Sponsors

Hitachi general hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 65 years of age or older patients diagnosed with myelodysplastic syndrome patients who got written informed consent

Exclusion criteria

Exclusion criteria: patients who treat chemotherapy for hematological malignancy

Design outcomes

Primary

MeasureTime frame
5 years survival rate stratified by geriatric assessment tool

Secondary

MeasureTime frame
monthly hospital days stratified by geriatric assessment tool decrease rate of the score of EQ-5D-5L stratified by geriatric assessment tool remission rate by treatment intensity stratified by geriatric assessment tool survival rate by treatment intensity stratified by geriatric assessment tool

Countries

Japan

Contacts

Public ContactSuyama Takuya

Hitachi general hospital hematology,oncology

sutaku2468@yahoo.co.jp0294231111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026